Juan Mucci Selected Research

Chagas Disease (American Trypanosomiasis)

1/2021	Trypanosoma cruzi Induces B Cells That Regulate the CD4+ T Cell Response.
1/2020	Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.
1/2019	Metabolic Labeling of Surface Neo-sialylglyconjugates Catalyzed by Trypanosoma cruzi trans-Sialidase.
1/2019	Molecular and antigenic characterization of Trypanosoma cruzi TolT proteins.
10/2017	Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes.
4/2016	Sialic Acid Glycobiology Unveils Trypanosoma cruzi Trypomastigote Membrane Physiology.
7/2015	Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants.
5/2015	Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells.
7/2006	The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation.
1/2005	The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Mucci Research Topics

Disease

13	Chagas Disease (American Trypanosomiasis) 01/2021 - 03/2002
8	Infections 01/2021 - 08/2002
1	Leishmaniasis 10/2017
1	Communicable Diseases (Infectious Diseases) 07/2015
1	Persistent Infection 10/2006
1	Thrombocytopenia (Thrombopenia) 01/2005

Drug/Important Bio-Agent (IBA)

6	trans-sialidaseIBA 01/2020 - 03/2002
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2020 - 01/2005
3	EnzymesIBA 01/2019 - 01/2005
3	Virulence Factors (Pathogenicity Factors)IBA 05/2015 - 01/2005
2	AntibodiesIBA 01/2021 - 06/2006
2	Peptides (Polypeptides)IBA 10/2017 - 07/2015
2	EpitopesIBA 10/2017 - 07/2015
2	VaccinesIBA 10/2017 - 07/2015
1	interleukin-21 (interleukin 21)IBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2020
1	Recombinant ProteinsIBA 01/2019
1	GlycoconjugatesIBA 01/2019
1	MucinsIBA 01/2019
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 10/2017
1	Sialic AcidsIBA 04/2016
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	OvalbuminIBA 05/2015
1	Interleukin-2 (IL2)IBA 05/2015
1	Interleukin-4 (Interleukin 4)IBA 05/2015
1	Interferon-gamma (Interferon, gamma)IBA 05/2015
1	Proteins (Proteins, Gene)FDA Link 06/2014
1	Interleukin-17 (Interleukin 17)IBA 05/2013
1	MitogensIBA 10/2006
1	CarboxypeptidasesIBA 09/2003